Metabomed For Profit
Metabomed designs drugs designed treats cancer. Its drugs target the reprogrammed cancer cell's metabolism to halt their growth, enabling patients to begin their treatment more quickly and result in a higher likelihood of a successful treatment.
Founded Date:
2014-01-01
Headquarters:
Yavne, HaMerkaz, Israel
Technology:
Drug development
Industry:
PharmTech
Estimated Revenue:
$1.9Mper year